Large-scale genetic study of hereditary spherocytosis (HS) is complicated by the lack of well defined criteria for diagnosis of mildly affected cases. This paper presents a study of 181 members of 26 families in which normal members and affected members were classified by analysis of multiple laboratory tests.
Hereditary spherocytosis is a familial hemolytic disease characterized by abnormal thickness of the erythrocyte. The spleen preferentially traps and destroys these abnormally shaped cells (1, 2) . The hemolysis that results from this normal function of the spleen is terminated by splenectomy. Recent studies have turned from the mechanism of splenic trapping (still unclear) to the cause of sphering. Metabolic defects in the spherocyte were described by Prankerd, Altman and Young (3) in 1955, and recently Prankerd (4) has shown evidence that the metabolic changes are of greater significance to hemolysis than is the shape change. However, the metabolic defects are thought not to be pathognomonic of HS (5) . Some evidence has been recently introduced showing that the membrane content of phosphatidyl ethanolamine is decreased (6) . To date no unique enzyme defect has been demonstrated. In the absence of a specific diagnostic measurement we are compelled to rely on conventional hematologic procedures including standardized measurements of red cell fragility: osmotic fragility, autohemolysis, and mechanical fragility.
The diagnosis of hereditary spherocytosis can be made with certainty only with laboratory aid and family study. Although some severe cases with clinical jaundice, splenomegaly, anemia, and * Supported by a research grant from the National Institutes of Health.
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gall stones have occurred in every series, minimally affected cases have also been encountered, so that as early as 1925 Campbell and Warner (7) cautioned against excluding the disease without laboratory data. Contemporary literature does not make clear the amount of laboratory data required to establish the presence -or absence of HS.
Race (8) made the largest of modern family studies 20 years ago but did not describe the laboratory tests used to ascertain his cases. Abrams and Battle (9) appear to have based their genetic conclusions on measurement of red cell diameters, using the Hayden erythrocytometer. Although Young, Izzo and Platzer (10) do not emphasize their method of diagnosis or ascertainment, they state that the mechanical fragility was elevated in every affected case. Genetic studies of spherocytic families often produce data at variance with the pattern predicted for a single, simple Mendelian dominant. The most frequent abnormality is failure to show 50 per cent incidence in siblings, offspring, and parents of those affected. Young and co-workers (10) found a shortage of affected siblings, which they attributed to low gene penetrance, and a significant number of sporadic cases. In a larger study Race (8) also found a shortage of affected siblings which he attributed to a high incidence of miscarriages and fetal deaths. However, single reports (9, 11 ) of large families may show 50 per cent affected. One genetic study suggests that there is an excess of affected males, an unexpected finding in a simple Mendelian dominant (9) . Another genetic study indicates that more than one type of hereditary spherocytosis may exist (12) . The reader is referred to Dacie (13) for a comprehensive review.
In this study we have established methods for ascertaining affected and normal subjects in HS 554 Tables I-IV give data for four groups: I, normal controls; II, nonaffected family members; III, affected relatives with spleen intact; and IV, affected relatives after splenectomy. Table V gives the means and standard deviations for the several laboratory tests of these four groups.
Multiple correlation coefficients for various combinations of laboratory tests are given in Table VI . These coefficients were determined by comparing the controls with the classical cases of HS. If the distributions were normal and the variances the same for these two groups, and if affected persons were representative of all carriers instead of clearly affected cases, there would be a simple relationship between the correlation coefficients and the overlap. These conditions were not met, and we have no simple method of calculating the amount 
an excellent test for separating these two groups.
The high normal values are due in large part to the use of brilliant cresyl blue rather than the new methylene blue. Figure 2 shows the distribution of spherocyte scores for normal and affected subjects. There was a tendency to over-read normal smears. This was noticed by the examiners especially when five or more normal smears were studied in succession. Seventeen When values for reticulocytes, hemoglobin, bilirubin, and spherocytes were combined to form a discriminant, D4, six discrepancies between D4 and the physician's diagnosis were found among 159 family members with spleens. This is a 3.7 per cent discordance, using four tests. When all 13 tests were used to form a discriminant, Dc, three discrepancies between Dc and the physician's diagnosis were found among 110 family members. This is a 2.7 per cent discordance, using 13 tests.
DISCUSSION
The problem of diagnosis or ascertainment of hereditary spherocytosis for genetic analysis differs from classical medical diagnosis in several respects. The emphasis is on detection of disease in people who consider themselves well rather than proving that a given case of hemolytic anemia is typical of hereditary spherocytosis. The physician working with a sick patient may conveniently repeat a variety of laboratory tests until the diagnosis is certain. Ideally the medical geneticist would make a single quantitative measurement that would segregate the members of HS families into two groups. To date such a measurement has not become available. We must rely on a number of tests which describe the syndrome of hereditary spherocytosis. For genetic purposes we must make the group of tests large enough so that we can draw a correct conclusion from a single sample of blood, since daily fluctuations are expected for each test in the same individual and we are not likely to be able to re-study any significant number of these individuals.
What tests are available and how are they interpreted? Elevation of the reticulocyte count indicates increased red cell production. An increased indirect bilirubin suggests a hemolytic process, but increased values are found in other diseases-e.g., Gilbert's disease. Elevated osmotic fragility correlates with spherocytosis (23) . Examination of the blood smear is the only way yet devised to demonstrate spherocytes, but it is the least objective of the available tests. Mechanical fragility is also an indicator of spherocytosis, and appears to be more sensitive than the osmotic fragility test (24) . It is not specific, since ele- (25) . Red cells in acquired hemolytic anemias usually do not show significantly less autohemolysis with added glucose (20) . Autohemolysis may be of further value in separating HS into two types, since it has been reported that addition of adenosine changes phosphorylated intermediates toward normal in some families and not in others (12) . Quantitative estimates of the correlations of these tests are given in Table VII . These estimates were made from the data of normal controls and classical cases of hereditary spherocytosis. They are not necessarily valid for normals alone, or for other hematologic diseases. The spherocyte score correlates most significantly with reticulocytes, mechanical fragility, 50 per cent osmotic fragility, and autohemolysis, in that order. The fragility tests are significantly and approximately equally correlated with each other; higher correlations are found within tests: 1 per cent osmotic fragility with 50 per cent osmotic fragility, and autohemolysis with autohemolysis plus glucose. The table also shows that a decrease in the mean corpuscular volume and an increase in the mean corpuscular hemoglobin concentration are correlated with increased fragility, as expected. Decreased hemoglobin and increased bilirubin are correlated with increased fragility.
Since the tests are highly intercorrelated, it is unlikely that all the tests are required to diagnose family members after the first case has been ascertained. There are two lines of evidence that establish this observation. The first is that comparison of the multiple correlation coefficients indicates little improvement in discrimination when a combination of all 13 tests is used instead of a combination of 4 tests. The multiple correlation coefficient is a discrimination ratio; that is, it gives a percentage value to the relative discriminative efficiency of various combinations of tests in separating the affected and normal groups. From the multiple correlation coefficients we can say that 78 per cent of the variability between the controls and 29 hand-picked affected is accounted for by the five fragility tests used to form Dh: autohemolysis, autohemolysis with glucose, osmotic fragility 1 per cent, osmotic fragility 50 per cent, and mechanical fragility. Eighty-eight per cent of the variability between the two groups is accounted for by four simple laboratory tests used to form D4: hemoglobin, reticulocyte count, bilirubin, and spherocyte score. The multiple correlation coefficient for D5, adding values for mechanical fragility to the four values used to form D4, is increased only slightly (to 90 per cent) over D4. The correlation coefficient for the complete discriminant using 13 tests is 91 per cent. Since the difference between the correlation coefficients for D4 and Dc is small, the difference in discriminative effectiveness between these two groups of tests is also small.
The second line of evidence is that there is no appreciable change in the discrepancy between the computer diagnosis and the physician's diagnosis when 13 tests are used instead of 4. There was a 3.7 per cent discrepancy between D4 and the physician's diagnosis, and 2.7 per cent discrepancy between Dc and the physician's diagnosis. We conclude that there is little to be gained in doing more than these four tests on members of a family in which one typical case of hereditary spherocytosis has been found. These four tests in order of their importance to the discriminant D4 are: 1) spherocyte score, 2) reticulocyte count, 3) hemoglobin, 4) bilirubin. When the fragility tests and indices are added to these four simple hematologic tests there is a small improvement in discrimination. Although we considerd the possibility that statistical analysis of multiple laboratory tests could result in detection of mildly affected cases that might be missed on inspection, we disagreed with the complete discriminant scores in three doubtful cases. Study of these three individuals gives some clues to the cause of the disagreements.
A 74 year old man, 168202, was considered by the physician to be affected on the basis of readily palpable spleen and a suggestive elevation of the autohemolysis. We feel that this conclusion is correct because subsequent study shows that a sister and a son have typical hereditary spherocytosis.
A 56 year old woman, 172302, was considered to be normal by the physician on the basis of normal bilirubin and reticulocytes, although the spherocyte score was 2 and other laboratory data were equivocal. We think this conclusion is correct because her medical history, genetic history, and physical examination were negative. She was the only normal spouse in the table of family members and was included because her husband (172303), by laboratory criteria, was unaffected; however, genetic studies indicated plainly that he was the genetic carrier. (This problem of unaffected carriers will be discussed in greater detail in a subsequent paper.)
A 26 year old man, 182308, was considered to be normal by the physician because the bilirubin and reticulocytes were normal. He was considered affected by statistical discrimination on the basis of a spherocyte score of 3. The physician's diagnosis was made before the statistical analysis was known. In restrospect, on the basis of the importance now attached to a spherocyte score of 3, the physician would have considered this man to be affected. The physician's judgment in the first case was based partially on a palpable spleen, information not used by the computer. In the second and third cases the physician's evaluation of the laboratory data, particularly the spherocyte score, difered from the computer analysis. We are not certain which evaluation is correct.
Obviously the criteria chosen by the physician and by the computer were not identical. Nevertheless there was good agreement between the physician's diagnosis and statistical evaluation by the computer. This good agreement indicates that the computer did not ascertain more mildly affected cases than could be diagnosed by the physician. We would predict from this that our genetic data would be similar to the data of other contemporary workers, assumed that sufficient laboratory values were available to them. This proved true.
We found an incidence of 0.51 ± 0.042 with a slight excess of males (0.56). The excess of affected males is not significant (14) except when pooled with the data of Young and colleagues (10), Race (8) , and Abrams and Battle (9) . The incidence of affected is higher than Race or Young and colleagues found, but the difference is not significant. Although criteria of ascertainment in work previously cited differed from ours or may not have been stated, we infer that the judgment of the physicians was based on enough data to draw conclusions similar to ours. We conclude that this method of discriminating normal from affected family members does not significantly increase the number of mildly affected cases that are detected, since the genetic data are statistically homogeneous with those of Race, Young and colleagues, and Abrams and Battle.
This study provides us with a quantitative determination of tests needed to diagnose family members correctly. Ninety-seven per cent of the cases was correctly classified by tests arbitrarily chosen as the most generally available: the smear, reticulocyte count, hemoglobin, and bilirubin. This does not discredit the fragility tests, since they contribute a significant amount of information when used independent of other measurements. But they have proved to be uneconomical except in diagnosing the primary case in a family and other isolated cases of hemolytic anemia. The formula for the discriminant D4 is considered 565 to be applicable to other family studies of hereditary spherocytosis, provided that controls are used to determine distribution of discriminant scores for normal subjects in other laboratories.
Data from this study can practicably be pooled with data from Race (8), Young and co-workers (10), and Abrams and Battle (9) . With this larger volume of data we are able to investigate problems of fitness, incidence, and mutation that are not yet solved for hereditary spherocytosis.
SUMMARY
We have studied 181 members of 26 families with hereditary spherocytosis. Means and standard deviations for 12 tests have been calculated for four groups: controls, normal family members, affected family members with spleens intact, and affected family members after splenectomy.
Correlations of tests individually indicated many significant interrelationships. Correlations of groups of tests indicated that 4 tests (spherocyte score, reticulocyte count, hemoglobin, and bilirubin) accounted for 88 per cent of the variability between normal subjects and classical cases of hereditary spherocytosis, whereas 13 tests accounted for 91 per cent of the variability. Addition of mehanical fragility to the four tests mentioned accounted for 90 per cent of the variability between the two classes.
Discriminant scores for 4 tests (D4) and 13 tests (Dc) were made for family members and normal controls. When these were compared with the physician's evaluation, there was a 3.7 per cent discrepancy between the physician and D4, and a 2.7 per cent discrepancy between the physician and Dc.
Diagnosis of family members with hereditary spherocytosis does not ordinarily require more than four tests after the initial case has been studied.
Genetic data from this study give a higher incidence of affected than do other contemporary investigations, but the difference is not statistically significant.
